Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice

Alfonso Calvo, Andrew L. Feldman, Steven K. Libutti, Jeffrey E. Green

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

We demonstrate the efficacy of systemic administration of a replication-defective adenovirus expressing endostatin (Ad-mEndo) administered during the preinvasive stage of mammary tumor development in C3(1)/T antigen transgenic mice. Mean serum levels of endostatin increased about 8-fold above that of controls and resulted in a significant decrease in tumor growth and an increase in survival. The inhibitory effect of endostatin occurred during or after the progression to invasive carcinoma. Reduced levels of vascular endothelial growth factor mRNA were found in association with high levels of endostatin. Our results demonstrate that the adenoviral induction of high levels of circulating endostatin significantly inhibits mammary tumor growth during the period when the "angiogenic switch" occurs.

Original languageEnglish (US)
Pages (from-to)3934-3938
Number of pages5
JournalCancer Research
Volume62
Issue number14
StatePublished - Jul 15 2002
Externally publishedYes

Fingerprint

Endostatins
Polyomavirus Transforming Antigens
Human Mammary Glands
Adenoviridae
Transgenic Mice
Breast Neoplasms
Growth
Viral Tumor Antigens
Vascular Endothelial Growth Factor A
Carcinoma
Messenger RNA
Serum
Neoplasms

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice. / Calvo, Alfonso; Feldman, Andrew L.; Libutti, Steven K.; Green, Jeffrey E.

In: Cancer Research, Vol. 62, No. 14, 15.07.2002, p. 3934-3938.

Research output: Contribution to journalArticle

Calvo, Alfonso ; Feldman, Andrew L. ; Libutti, Steven K. ; Green, Jeffrey E. / Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice. In: Cancer Research. 2002 ; Vol. 62, No. 14. pp. 3934-3938.
@article{1ac81de621824c43aae19e435cd0ed30,
title = "Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice",
abstract = "We demonstrate the efficacy of systemic administration of a replication-defective adenovirus expressing endostatin (Ad-mEndo) administered during the preinvasive stage of mammary tumor development in C3(1)/T antigen transgenic mice. Mean serum levels of endostatin increased about 8-fold above that of controls and resulted in a significant decrease in tumor growth and an increase in survival. The inhibitory effect of endostatin occurred during or after the progression to invasive carcinoma. Reduced levels of vascular endothelial growth factor mRNA were found in association with high levels of endostatin. Our results demonstrate that the adenoviral induction of high levels of circulating endostatin significantly inhibits mammary tumor growth during the period when the {"}angiogenic switch{"} occurs.",
author = "Alfonso Calvo and Feldman, {Andrew L.} and Libutti, {Steven K.} and Green, {Jeffrey E.}",
year = "2002",
month = "7",
day = "15",
language = "English (US)",
volume = "62",
pages = "3934--3938",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "14",

}

TY - JOUR

T1 - Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice

AU - Calvo, Alfonso

AU - Feldman, Andrew L.

AU - Libutti, Steven K.

AU - Green, Jeffrey E.

PY - 2002/7/15

Y1 - 2002/7/15

N2 - We demonstrate the efficacy of systemic administration of a replication-defective adenovirus expressing endostatin (Ad-mEndo) administered during the preinvasive stage of mammary tumor development in C3(1)/T antigen transgenic mice. Mean serum levels of endostatin increased about 8-fold above that of controls and resulted in a significant decrease in tumor growth and an increase in survival. The inhibitory effect of endostatin occurred during or after the progression to invasive carcinoma. Reduced levels of vascular endothelial growth factor mRNA were found in association with high levels of endostatin. Our results demonstrate that the adenoviral induction of high levels of circulating endostatin significantly inhibits mammary tumor growth during the period when the "angiogenic switch" occurs.

AB - We demonstrate the efficacy of systemic administration of a replication-defective adenovirus expressing endostatin (Ad-mEndo) administered during the preinvasive stage of mammary tumor development in C3(1)/T antigen transgenic mice. Mean serum levels of endostatin increased about 8-fold above that of controls and resulted in a significant decrease in tumor growth and an increase in survival. The inhibitory effect of endostatin occurred during or after the progression to invasive carcinoma. Reduced levels of vascular endothelial growth factor mRNA were found in association with high levels of endostatin. Our results demonstrate that the adenoviral induction of high levels of circulating endostatin significantly inhibits mammary tumor growth during the period when the "angiogenic switch" occurs.

UR - http://www.scopus.com/inward/record.url?scp=0037099521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037099521&partnerID=8YFLogxK

M3 - Article

VL - 62

SP - 3934

EP - 3938

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 14

ER -